- Batch correction and data integration are important computational procedures in bioinformatics, particularly in single-cell RNA sequencing (scRNA-seq), genomics, transcriptomics, and multi-omics research. Biological datasets are frequently generated from different experiments, laboratories, sequencing platforms, tissue samples, or experimental batches. Although these datasets may represent the same biological system, technical differences can introduce systematic variations that are unrelated to the biological processes under investigation. These variations are known as batch effects. Batch correction aims to reduce unwanted technical differences, while data integration combines multiple datasets into a unified analytical framework. Together, these approaches improve the ability to compare biological samples, identify shared cellular populations, investigate disease mechanisms, and analyse large-scale biological datasets.
- A batch effect occurs when measurements differ systematically because of technical or experimental factors rather than genuine biological variation. For example, two single-cell RNA-seq experiments performed on different days may produce different gene-expression profiles because of variations in tissue handling, cell isolation, RNA quality, library preparation, sequencing depth, reagent batches, or sequencing instruments. Differences can also arise from laboratory protocols, operators, computational pipelines, and sequencing technologies. In bulk RNA sequencing, batch effects may influence gene-expression measurements, while in single-cell experiments they can affect individual cell profiles, clustering, and cell-type identification. If these effects are not appropriately controlled, cells from the same biological population may appear artificially different, or unrelated cell populations may appear more similar than they actually are.
- Batch effects can be identified through exploratory data analysis and visualization. Principal component analysis (PCA) is commonly used to examine major sources of variation in gene-expression data. If samples or cells group according to experimental batch rather than biological condition, this may indicate a batch effect. UMAP and t-distributed stochastic neighbour embedding (t-SNE) can also help visualize differences among datasets, although their visual patterns should not be treated as definitive evidence. Researchers can examine sample-level distributions, library sizes, detected genes, expression profiles, and known control genes. Statistical methods can also estimate whether technical variables explain a substantial proportion of observed variation. Importantly, separation by batch is not always evidence of an unwanted technical effect: batches may also contain genuine biological differences, especially when experimental conditions, tissues, developmental stages, or disease groups are not balanced across batches.
- Batch correction attempts to remove unwanted technical variation while preserving meaningful biological differences. In bulk gene-expression studies, methods such as ComBat, ComBat-seq, limma, and surrogate variable analysis (SVA) are commonly used. ComBat uses an empirical Bayes framework to estimate and adjust batch-associated differences, while ComBat-seq is designed for RNA-seq count data and uses negative binomial modelling. Limma provides linear modelling and empirical Bayes methods for expression analysis, and SVA estimates latent sources of unwanted variation that may influence the data. These methods are generally applied with attention to the experimental design and the distinction between technical and biological variables.
- In single-cell transcriptomics, batch correction is often performed as part of data integration. Instead of simply modifying expression measurements, many methods identify shared biological structures across datasets and align comparable cells or cellular populations. This is important because single-cell datasets can contain thousands or millions of cells, with substantial variation in cell composition, gene detection, and cellular states. Integration methods aim to identify corresponding populations across experiments while reducing technical differences between them. The resulting integrated representation can be used for joint visualization, clustering, cell-type annotation, and comparative analysis.
- Several computational methods are widely used for single-cell data integration. Seurat integration uses selected features and anchor-based approaches to identify correspondences between datasets and construct an integrated representation. Harmony performs iterative correction in a reduced-dimensional space, adjusting principal components to reduce batch-associated separation while preserving biological structure. fastMNN uses mutual nearest neighbours to identify corresponding cells across datasets and correct differences in their low-dimensional representations. Scanorama identifies similar cellular populations across datasets and integrates them using mutual nearest-neighbour relationships. scVI, part of the scvi-tools framework, uses probabilistic deep-learning models to represent gene-expression data and account for technical variation. BBKNN modifies the neighbourhood graph by balancing the contribution of cells from different batches, while LIGER uses integrative non-negative matrix factorization to identify shared and dataset-specific factors.
- Other methods include mutual nearest neighbours (MNN), canonical correlation analysis (CCA), reciprocal PCA, and variational autoencoders. These approaches differ in their assumptions, computational requirements, and treatment of biological and technical variation. Some operate on normalized expression matrices, while others use raw count data or reduced-dimensional representations. The choice of method depends on dataset size, number of batches, sequencing technology, biological complexity, and the intended downstream analysis. No single integration method is optimal for every experiment.
- A typical single-cell integration workflow begins with quality control of each dataset independently. Researchers remove low-quality cells, identify potential doublets, evaluate mitochondrial gene expression, and examine sequencing characteristics. Each dataset is then normalized using an appropriate method, and highly variable genes are selected. Integration features or shared genes are identified, and the chosen algorithm is applied to construct a corrected representation. The integrated datasets are subsequently examined using PCA, UMAP, or other visualization approaches. Clustering and cell-type annotation can then be performed using shared biological patterns across datasets. Tools such as Seurat, Scanpy, Harmony, fastMNN, Scanorama, and scvi-tools support different stages of this process.
- Data integration can involve more than correcting batches from the same type of experiment. In transcriptomics, researchers may combine datasets from different tissues, developmental stages, disease conditions, species, or sequencing platforms. This allows the investigation of shared and distinct gene-expression patterns across biological contexts. For example, integrating single-cell datasets from healthy and diseased tissues can help identify common cell types and compare disease-associated cellular states. Integrating datasets from multiple developmental stages can reveal changes in cell populations and gene-expression programmes over time. However, integration must not erase genuine differences that are central to the biological question.
- An important distinction exists between batch correction and data integration. Batch correction focuses on reducing systematic technical variation associated with experimental batches. Data integration is a broader process that combines datasets so they can be analysed together. Integration may include batch correction, feature matching, normalization, cell-type alignment, and the identification of shared or dataset-specific biological patterns. Some integration methods correct technical variation directly, whereas others generate a shared low-dimensional representation without modifying the original expression measurements. Therefore, the integrated representation should not automatically be treated as a replacement for the original gene-expression data.
- One of the greatest challenges in batch correction is preserving biological variation. If a biological condition is strongly associated with a particular batch, technical and biological effects may become difficult or impossible to distinguish statistically. For example, if all healthy samples are processed in one batch and all diseased samples in another, an algorithm may remove genuine disease-associated expression differences along with technical variation. This problem is known as confounding. Appropriate experimental design is therefore essential. Whenever possible, biological conditions should be distributed across batches, and samples should be processed using consistent protocols. Experimental metadata, including sample identity, condition, tissue, sequencing platform, and batch information, should be carefully recorded.
- Overcorrection is another important limitation. If an integration algorithm removes too much variation, biologically distinct cell populations may be incorrectly merged, disease-associated states may disappear, and meaningful differences between tissues or developmental stages may be reduced. Under-correction, on the other hand, leaves technical differences that can dominate clustering and downstream interpretation. Integration quality should therefore be evaluated using both technical and biological criteria. Methods such as kBET, LISI, graph connectivity, and silhouette scores can help assess batch mixing and biological separation. The iLISI metric evaluates batch mixing, whereas cLISI evaluates cell-type separation when suitable cell-type labels are available. Benchmarking frameworks such as scIB compare integration methods using multiple metrics rather than relying on a single measure.
- Batch correction and integration also require careful consideration when analysing differential gene expression. Many integration methods produce corrected embeddings or latent representations intended for visualization and clustering, not corrected gene-expression counts suitable for ordinary differential-expression testing. Researchers should generally perform statistical comparisons using appropriately normalized original expression data or sample-level pseudobulk counts, with batch variables included in the statistical model where appropriate. Integrated embeddings can support cell matching and annotation, but they should not automatically be used as input for gene-level statistical tests. This distinction helps prevent misleading conclusions about gene-expression differences.
- Data integration is increasingly important in multi-omics research, where different types of biological measurements are combined to obtain a more comprehensive understanding of molecular systems. Transcriptomics, genomics, epigenomics, proteomics, metabolomics, and chromatin-accessibility data provide complementary information. For example, RNA sequencing measures gene expression, ATAC-seq measures chromatin accessibility, DNA methylation analysis investigates epigenetic regulation, and proteomics measures protein abundance. Integration can identify relationships between genetic variation, regulatory mechanisms, gene expression, and cellular function. Tools such as Seurat, MOFA+, totalVI, MultiAssayExperiment, and other specialized frameworks support different forms of multi-omics analysis. The integration strategy must account for differences in data structure, measurement scale, missing values, and biological resolution.
- Batch correction and data integration have broad applications in biomedical research, cancer biology, immunology, developmental biology, neuroscience, microbiology, and drug discovery. They enable researchers to combine independent studies, increase the number of analysed samples, identify rare cell populations, and compare biological systems across experimental conditions. In cancer research, integration of datasets from different patients and tumour regions can help characterize tumour heterogeneity and immune-cell populations. In immunology, combining datasets from different tissues and disease conditions can reveal shared immune-cell states. In drug discovery, integrated datasets can help compare cellular responses to different treatments and identify pathways associated with therapeutic response or resistance.
- These approaches are also valuable in animal genomics, veterinary science, and livestock research. Single-cell and bulk transcriptomic datasets from cattle, sheep, goats, pigs, poultry, and other species may be generated by different research groups, laboratories, sequencing platforms, and experimental protocols. Integration can help compare gene-expression patterns across breeds, tissues, developmental stages, environmental conditions, and disease states. For example, combining mammary-gland datasets may reveal common epithelial and immune-cell populations associated with lactation and mastitis. Integrating muscle datasets may help investigate cellular populations and gene-expression programmes involved in growth, muscle development, and meat quality. Cross-breed and cross-species integration may also help identify conserved biological pathways and species-specific differences. Such findings can be connected with quantitative genetics, genome-wide association studies, genomic selection, and functional genomics to investigate the molecular basis of economically important traits.
- Despite their benefits, batch correction and data integration have several limitations. Different studies may use incompatible gene annotations, sequencing protocols, reference genomes, sample preparation procedures, and data-processing pipelines. Rare cell types may be absent from some datasets, while differences in tissue composition can complicate alignment. Cross-species integration is particularly challenging because gene orthology, genome annotation, and evolutionary divergence must be considered. Large datasets can also require substantial memory and computational resources. Researchers should therefore document preprocessing decisions, retain original data and metadata, select methods appropriate to the biological question, and evaluate integration quality using independent biological evidence.
- Overall, batch correction and data integration are essential for combining biological datasets while controlling unwanted technical variation. Batch correction reduces experimental differences that may interfere with biological interpretation, whereas integration provides a framework for analysing multiple datasets together. When performed carefully, these approaches improve the reliability of cell clustering, cell-type identification, cell-state characterization, differential-expression analysis, and multi-omics research. Their success depends on sound experimental design, appropriate computational methods, preservation of genuine biological variation, and thorough evaluation of the integrated results.